Generics - Asia-Pacific, Pricing

Filter

Current filters:

Asia-PacificPricing

Popular Filters

1 to 25 of 46 results

NZ’s PHARMAC tender reveals vibrant market for pharmaceuticals

NZ’s PHARMAC tender reveals vibrant market for pharmaceuticals

12-02-2014

The number of companies bidding to be suppliers through PHARMAC, New Zealand’s Pharmaceutical Management…

Asia-PacificGenericsHealthcarePricing

Mixed views on Grattan Institute report on drug price cuts impact in Australia

Mixed views on Grattan Institute report on drug price cuts impact in Australia

03-12-2013

The Grattan Institute has published an updated report on Australia's drug pricing, which has been applauded…

Asia-PacificAustraliaGenericsPoliticsPricing

Japan’s MoF seen as another opponent to premium system

Japan’s MoF seen as another opponent to premium system

29-10-2013

The Budget Bureau of Japan’s Ministry of Finance, in a meeting of the Fiscal System Council last week,…

Asia-PacificGenericsPharmaceuticalPricing

Rise or demise of Japan’s generics by P Reed Maurer

Rise or demise of Japan’s generics by P Reed Maurer

16-10-2013

Generics in Japan are a work in progress. Presently they account for about 28% of pharmaceutical volume,…

Asia-PacificGenericsMarkets & MarketingPricing

Generics market in Southeast Asia set for growth

15-09-2013

With its fast-growing, young population and uninsured majority in Southeast Asia, countries in the region…

Asia-PacificGenericsMarkets & MarketingPricingRegulation

UNITAID helps accessing quality drugs at affordable prices

03-09-2013

At an interactive session with Indian pharmaceuticals and diagnostics industry leaders organized by the…

Asia-PacificGenericsGlobalHealthcarePharmaceuticalPricing

Stability in the Australia's PBS relies on increased use of generic medicines

29-08-2013

Australia's Generic Medicines Industry Association (GMiA) welcomes the Health Debate at the National…

Asia-PacificFinancialGenericsHealthcarePricing

Japan's MHLW approves 367 generics, but what does this mean?

21-08-2013

Japan's Ministry of Health Labor and Welfare (MHLW) approved 367 items of generic drugs last week. Launch…

Asia-PacificDiovanGenericsNovartisPharmaceuticalPricingRegulation

Australian Pharmacy Guild takes its case to the public

12-08-2013

Pharmacy patients around Australia are being urged to rally against a shock federal government decision…

Asia-PacificFinancialGenericsPricing

Japanese government committee has kicked off reform on drug pricing system

05-08-2013

Revision of drug pricing rules in Japan gained momentum when the Council of Regulatory Reforms (CRR)…

Asia-PacificGenericsPharmaceuticalPricing

Medecins Sans Frontieres wants the Trans-Pacific Partnership to amend terms

16-07-2013

Worldwide humanitarian organization Medecins Sans Frontieres (MSF) is urging the countries participating…

Asia-PacificGenericsPatentsPharmaceuticalPricing

Generic medicines pricing reforms deliver significant savings to Australian government, says CSES report

22-05-2013

Australia's 2010 Pharmaceutical Benefits Scheme (PBS) reforms have delivered the government significant…

Asia-PacificFinancialGenericsHealthcarePharmaceuticalPricing

Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines

20-05-2013

India's National Pharmaceutical Pricing Authority (NPPA) last week announced plans that will bring down…

Asia-PacificGenericsPharmaceuticalPricing

Australia's 2013-14 Budget includes investment in health services and PBS

14-05-2013

The Australian government today (May 14) presented its Budget for 2013-2014, saying that it delivers…

Asia-PacificFinancialGenericsPharmaceuticalPoliticsPricing

Activists protest in front of the European Parliament to stop EU-India trade deal "harmful" provisions

09-04-2013

As European Commission pressure mounts on India to rush into signing a free trade agreement (FTA) by…

Asia-PacificEuropeGenericsPatentsPharmaceuticalPoliticsPricing

For first time in 20 years, Australia's PBS spending in decline

22-03-2013

For the first time in 20 years government expenditure on the Pharmaceutical Benefits Scheme (PBS) in…

Asia-PacificFinancialGenericsHealthcarePharmaceuticalPricing

Generic medicines policies are driving significant savings in Australia, claims GMiA

18-03-2013

Australian taxpayers and patients alike benefit from having increased access to the more affordable generic…

Asia-PacificGenericsHealthcarePharmaceuticalPricing

Further savings expected following Australian Crestor patent decision, says GMiA

07-03-2013

In a decision brought down by the Australian Federal Court earlier this week, suppliers of generic medicines…

Asia-PacificAstraZenecaCardio-vascularCrestorGenericsPatentsPharmaceuticalPricing

PHARMAC holding back New Zealand health care industry growth, says GlobalData

26-02-2013

Despite disproportionate elderly population growth and an unsaturated market acting as key drivers, growth…

Asia-PacificGenericsMarkets & MarketingPharmaceuticalPricing

Australia's protectionist generic medicines plan flawed, says trade group

14-02-2013

Proposals from a handful of generic medicines companies for the Australian Pharmaceutical Benefits Scheme…

Asia-PacificGenericsHealthcarePharmaceuticalPricing

Japan Pharma: Expectations for 2013, by P Reed Maurer

03-01-2013

The biggest non-event in the Japan health care market during 2013 will be no reimbursement price reductions,…

Asia-PacificGenericsLicensingMergers & AcquisitionsPharmaceuticalPricingResearch

Indian government endorses plan to cap prices of 348 drugs

23-11-2012

India's Union Cabinet yesterday endorsed the Group of Ministers' (GoM) recommendations on the National…

Asia-PacificGenericsPharmaceuticalPoliticsPricing

Indian govt pressed to adopt market-based drug pricing by ASSOCHAM

22-11-2012

India's Associated Chambers of Commerce and Industry (ASSOCHAM) believes that the Supreme Court ruling…

Asia-PacificGenericsPharmaceuticalPoliticsPricing

India's Cipla cuts prices of three cancer drugs

12-11-2012

Following what Indian drugmaker Cipla (BSE: 500087) said was an "overwhelming response" on the price…

Asia-PacificcapecitabineCipladocetaxelerlotinibGenericsOncologyPatentsPfizerPharmaceuticalPricingSunitinib MalateSutent

1 to 25 of 46 results

Back to top